JUSONDO
Live / Allowed — Publication / registration review complete (as of 26 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99485035
- Mark type
- Stylized text
- Filed
- 07 Nov 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Owner
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 20 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2026 — ASSIGNED TO EXAMINER
- 15 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Nov 2025 — NEW APPLICATION ENTERED